Sort   by:  
 Page size 
ProteomicsSite-specific analysis of CD16a and CD32a N-glycosylation from monocytes display donor variability which modulate affinity to IgG1 Fc
Glycopeptide mass spectra of CD16a and CD32a from isolated monocytes display donor and site variability. CD16a N-glycosylation composition affects the affinity of IgG1 Fc. Peptide coverage of CD16a was ~85% while CD32a was ~61%.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2019-06-26 | MSV000084012 | MassIVE
ProteomicsAllotype-specific processing of the CD16a N45-glycan from primary human natural killer cells and monocytes
Two datasets that contain the less common CD16a H48 allele
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2020-01-13 | MSV000084795 | MassIVE
UnknownAccelarated immune ageing is associated with COVID-19 disease severity.
Not available
S-EPMC10782727 | biostudies-literature
UnknownMortality after surgery in Europe: a 7 day cohort study.
Not available
S-EPMC3493988 | biostudies-literature
UnknownIndividual common variants exert weak effects on the risk for autism spectrum disorders.
Not available
S-EPMC3471395 | biostudies-literature
UnknownPost-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury.
Not available
S-EPMC10789589 | biostudies-literature
UnknownSARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination.
Not available
S-EPMC9762734 | biostudies-literature
UnknownCohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study.
Not available
S-EPMC10859139 | biostudies-literature
UnknownLong term health outcomes in people with diabetes 12 months after hospitalisation with COVID-19 in the UK: a prospective cohort study.
Not available
S-EPMC11743801 | biostudies-literature
UnknownEffects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study.
Not available
S-EPMC10156429 | biostudies-literature
Sort   by:  
 Page size